[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001249431A1 - Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer - Google Patents

Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer

Info

Publication number
AU2001249431A1
AU2001249431A1 AU2001249431A AU4943101A AU2001249431A1 AU 2001249431 A1 AU2001249431 A1 AU 2001249431A1 AU 2001249431 A AU2001249431 A AU 2001249431A AU 4943101 A AU4943101 A AU 4943101A AU 2001249431 A1 AU2001249431 A1 AU 2001249431A1
Authority
AU
Australia
Prior art keywords
diganosing
staging
imaging
compositions
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249431A
Inventor
Robert Cafferkey
Ping Hu
Herve Recipon
Susana Salceda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of AU2001249431A1 publication Critical patent/AU2001249431A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001249431A 2000-03-27 2001-03-26 Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer Abandoned AU2001249431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19227700P 2000-03-27 2000-03-27
US60192277 2000-03-27
PCT/US2001/009525 WO2001072780A2 (en) 2000-03-27 2001-03-26 Polynucleotides for diagnosing mammary gland cancer

Publications (1)

Publication Number Publication Date
AU2001249431A1 true AU2001249431A1 (en) 2001-10-08

Family

ID=22709012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249431A Abandoned AU2001249431A1 (en) 2000-03-27 2001-03-26 Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer

Country Status (5)

Country Link
US (1) US6787335B2 (en)
EP (1) EP1278766A2 (en)
JP (1) JP2004501613A (en)
AU (1) AU2001249431A1 (en)
WO (1) WO2001072780A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072780A2 (en) 2000-03-27 2001-10-04 Diadexus, Inc. Polynucleotides for diagnosing mammary gland cancer
WO2002068645A2 (en) * 2000-11-20 2002-09-06 Diadexus, Inc. Compositions and methods relating to breast specific genes and proteins
US8832276B2 (en) * 2003-08-18 2014-09-09 International Business Machines Corporation Bypassing content blocking
EP2471923B1 (en) 2004-05-28 2014-08-20 Asuragen, Inc. Methods and compositions involving microRNA
JP2008519606A (en) 2004-11-12 2008-06-12 アンビオン インコーポレーティッド Methods and compositions relating to miRNA and miRNA-inhibiting molecules
WO2006086345A2 (en) * 2005-02-07 2006-08-17 The Trustees Of Columbia University In The City Of New York Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
US20060239398A1 (en) * 2005-03-07 2006-10-26 Fused Multimodality Imaging, Ltd. Breast diagnostic apparatus for fused SPECT, PET, x-ray CT, and optical surface imaging of breast cancer
CA2664383C (en) * 2006-09-19 2017-08-22 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
EP2198050A1 (en) 2007-09-14 2010-06-23 Asuragen, INC. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009070805A2 (en) 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
EP0832294A1 (en) * 1995-06-07 1998-04-01 Pioneer Hi-Bred International, Inc. PCR-BASED cDNA SUBTRACTIVE CLONING METHOD
US6680175B2 (en) 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
WO2001072780A2 (en) 2000-03-27 2001-10-04 Diadexus, Inc. Polynucleotides for diagnosing mammary gland cancer

Also Published As

Publication number Publication date
WO2001072780A2 (en) 2001-10-04
US6787335B2 (en) 2004-09-07
JP2004501613A (en) 2004-01-22
US20020037250A1 (en) 2002-03-28
WO2001072780A3 (en) 2002-04-11
EP1278766A2 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2001250932A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2001249431A1 (en) Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer
EP1317669A4 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
AU2002367023A1 (en) Compositions and methods for treating heart failure
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
AU2002365057A1 (en) Compositions and methods for treating heart failure
AU2002311859A1 (en) Compositions and methods for treating colorectal polyps and cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer